What Is the Spravato REMS Program?

Only a minority of medications have a REMS. When one exists, its requirements are not optional and are not set by the treating clinic — they are conditions of the drug’s approval.

The prescribing information states that Spravato is available only through a restricted program under a REMS because of the risks of serious adverse outcomes from sedation, dissociation, respiratory depression, and abuse and misuse. [FDA label]

Each of those risks is also addressed in the boxed warning. The program is the operational answer to them: if effects need direct observation and monitoring, the medication has to be given where that observation happens.

Two links in the supply chain must be certified:

• Healthcare settings must be certified in the program in order to dispense and administer Spravato.
• Pharmacies must be certified and may dispense Spravato only to certified healthcare settings.

[FDA label] A list of certified pharmacies and further program information is published by the program itself. [SPRAVATO REMS]

The practical effect is that Spravato never travels through an ordinary retail pharmacy to a patient. It moves from a certified pharmacy to a certified setting, and is used there.

The prescribing information states that patients treated in outpatient settings must be enrolled in the program. [FDA label] Enrollment is administered by the treating healthcare setting as part of starting treatment; patients do not arrange it independently.

REMS program requirements are periodically modified by the FDA. If a detail matters for your situation, the program’s own materials are the current authority. [SPRAVATO REMS]

The labeling specifies that Spravato is administered by the patient under the direct observation of a healthcare provider, and that the patient is then monitored by a healthcare provider. [FDA label]

“Direct observation” is literal: a provider is present while the spray is used, confirms the dose was delivered, and remains responsible for monitoring afterward. Monitoring includes blood pressure before the dose and at approximately 40 minutes, and respiratory status including pulse oximetry.

Patients are monitored for at least two hours after administration, then assessed for clinical stability before discharge. [FDA label]

The two hours are a minimum. Discharge depends on the clinical assessment, so a session can run longer if effects have not resolved. Any clinic offering a shorter observation period would not be following the requirement.

Because dispensing and administration are limited to certified healthcare settings, there is no prescription to fill at a local pharmacy and no supply to keep at home. [SPRAVATO REMS] Every dose is an appointment.

This is a defining practical difference between Spravato and oral antidepressants, and it is worth factoring into planning before treatment starts — see how often treatment is given.

The labeling instructs patients not to drive or operate machinery until the next day following a restful sleep. [FDA label] Transportation therefore has to be arranged for every session, throughout the course of treatment.

Certification establishes that a setting:

• has enrolled in the program and agreed to its requirements;
• may receive Spravato from a certified pharmacy;
• may dispense and administer it with the required observation and monitoring.

Certification does not establish that a clinic:

• provides better care than another certified clinic;
• has any particular level of experience or volume;
• achieves any particular outcomes;
• is endorsed, ranked, or recommended by the FDA.

Every setting that offers Spravato is certified — it is a precondition, not a differentiator. Marketing that presents certification as a mark of distinction is describing a minimum requirement.

The REMS program is why Spravato treatment looks the way it does: a certified setting, patient enrollment, self-administration under direct observation, at least two hours of monitoring, and no medication leaving the building. These are regulatory requirements that apply identically wherever the medication is given.

Certification tells you a setting is permitted to provide Spravato. It is not a credential, a ranking, or evidence of clinical quality, and any clinic presenting it that way is overstating what it means.